1. Home
  2. AVIR vs EVC Comparison

AVIR vs EVC Comparison

Compare AVIR & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.37

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$2.98

Market Cap

233.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVIR
EVC
Founded
2012
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
266.4M
233.8M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
AVIR
EVC
Price
$3.37
$2.98
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
393.0K
319.5K
Earning Date
11-12-2025
11-04-2025
Dividend Yield
N/A
6.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$420,178,000.00
Revenue This Year
N/A
$64.06
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.96
52 Week Low
$2.46
$1.58
52 Week High
$4.02
$3.44

Technical Indicators

Market Signals
Indicator
AVIR
EVC
Relative Strength Index (RSI) 53.27 49.33
Support Level $3.29 $2.84
Resistance Level $3.63 $3.11
Average True Range (ATR) 0.13 0.09
MACD -0.00 -0.03
Stochastic Oscillator 45.53 30.67

Price Performance

Historical Comparison
AVIR
EVC

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: